Home  /  Resource Library  /  Obinutuzumab atezolizumab lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial

Obinutuzumab atezolizumab lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial

Results of a study investigating obinutuzumab combined with atezolizumab and lenalidomide for treatment of relapsed follicular lymphoma.